Pitcairn Co. Sells 4,051 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pitcairn Co. cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.7% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 18,778 shares of the medical equipment provider’s stock after selling 4,051 shares during the period. Intuitive Surgical comprises approximately 0.5% of Pitcairn Co.’s holdings, making the stock its 28th largest holding. Pitcairn Co.’s holdings in Intuitive Surgical were worth $9,225,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Baillie Gifford & Co. lifted its position in Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after buying an additional 24,183 shares in the last quarter. American Century Companies Inc. increased its stake in shares of Intuitive Surgical by 3.0% during the 2nd quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock worth $1,066,837,000 after purchasing an additional 70,556 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Intuitive Surgical by 1.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,227,467 shares of the medical equipment provider’s stock worth $1,094,288,000 after purchasing an additional 28,703 shares during the last quarter. Clearbridge Investments LLC increased its stake in shares of Intuitive Surgical by 1.6% during the 2nd quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock worth $881,380,000 after purchasing an additional 30,449 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its stake in shares of Intuitive Surgical by 15.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider’s stock worth $659,893,000 after purchasing an additional 197,841 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently weighed in on ISRG shares. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday, October 18th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. Truist Financial boosted their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Finally, Leerink Partners upped their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $524.61.

Intuitive Surgical Stock Down 0.5 %

NASDAQ ISRG opened at $547.87 on Friday. The company has a market capitalization of $195.14 billion, a P/E ratio of 88.08, a P/E/G ratio of 5.41 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $304.50 and a 12-month high of $552.00. The firm has a 50-day moving average price of $504.73 and a two-hundred day moving average price of $463.02.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Equities analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, insider Jamie Samath sold 22,903 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the transaction, the insider now owns 8,757 shares of the company’s stock, valued at $4,597,425. This represents a 72.34 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Amy L. Ladd sold 450 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares of the company’s stock, valued at approximately $402,519.88. The trade was a 35.41 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 50,935 shares of company stock valued at $26,305,169. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.